Trying to wrap my head around the potential re-administration of AAV with chimeric AAV | SGMO Message Board Posts

Sangamo Therapeutics, Inc.

  SGMO website

SGMO   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  128477 of 135177  at  6/19/2019 2:23:04 PM  by

spaddy


 In response to msg 128460 by  GAGholder
view thread

Re: Trying to wrap my head around the potential re-administration of AAV with chimeric AAV

 "Trying to wrap my head around the potential re-administration of AAV with chimeric AAV"
 
Rethink the question..
 
Basically you are asking if a human is injected with a completely new engineered virus, how will the body respond.
 
We dont know until its actually injected in a human to test T cell response.
Ex vivo testing only tests for B cell response.
And mice and NHP respond differently to these viruses as well. 
That is the problem.
And Solid Biosciences and ONCE are seeing this problem first hand. 
 
But yes, people will need to try to improve specificity of targeting and efficacy of new modified viral vectors. ( Including SGMO)
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 5     Views: 286
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
128485 Re: Trying to wrap my head around the potential re-administration of AAV with chimeric AAV gg100 4 6/19/2019 3:04:34 PM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...